Myasthenia gravis and pregnancy: Lessons learned from a complex a case report

Area of Science:

• Neurology
• Immunology
• Obstetrics

Background:

• Myasthenia gravis (MG) predominantly affects young women, presenting unique challenges during pregnancy due to hormonal and immune system interplay.
• Pregnancy can modify MG course, while MG can impact pregnancy outcomes and fetal health.
• Understanding the bidirectional relationship between MG and pregnancy is crucial for optimal management.

Observation:

• A 28-year-old woman with a history of thymectomy and acetylcholinesterase inhibitor treatment for MG experienced a relapse during her third trimester.
• The relapse coincided with the development of severe hydramnios.
• This case illustrates a specific instance of MG decompensation during pregnancy.

Findings:

• Pregnancy-induced hormonal shifts and immune system changes can precipitate MG relapses.
• Severe hydramnios may be associated with MG decompensation during pregnancy.
• Anti-myasthenic treatments require careful consideration regarding their effects on pregnancy.

Implications:

• Close monitoring of MG patients throughout pregnancy is essential, particularly in the third trimester.
• Management strategies should address potential MG exacerbations and pregnancy complications like hydramnios.
• Further research is needed to fully elucidate the impact of MG treatments on pregnancy outcomes.